| Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma LE Abrey, TT Batchelor, AJM Ferreri, M Gospodarowicz, EJ Pulczynski, ... Journal of clinical oncology 23 (22), 5034-5043, 2005 | 885 | 2005 |
| Chemotherapy delivery issues in central nervous system malignancy: a reality check LL Muldoon, C Soussain, K Jahnke, C Johanson, T Siegal, QR Smith, ... Journal of clinical oncology 25 (16), 2295-2305, 2007 | 468 | 2007 |
| CNS complications of radiotherapy and chemotherapy C Soussain, D Ricard, JR Fike, JJ Mazeron, D Psimaras, JY Delattre The lancet 374 (9701), 1639-1651, 2009 | 459 | 2009 |
| Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology K Hoang-Xuan, E Bessell, J Bromberg, AF Hottinger, M Preusser, R Rudà, ... The Lancet Oncology 16 (7), e322-e332, 2015 | 377 | 2015 |
| Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma C Soussain, F Suzan, K Hoang-Xuan, N Cassoux, V Levy, N Azar, ... Journal of clinical oncology 19 (3), 742-749, 2001 | 335 | 2001 |
| Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Societe Francaise de Greffe de Moelle … C Soussain, K Hoang-Xuan, L Taillandier, E Fourme, S Choquet, F Witz, ... Journal of clinical oncology 26 (15), 2512-2518, 2008 | 331 | 2008 |
| Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas A Gonzalez-Aguilar, A Idbaih, B Boisselier, N Habbita, M Rossetto, ... Clinical cancer research 18 (19), 5203-5211, 2012 | 265 | 2012 |
| Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols C Soussain, C Patte, M Ostronoff, A Delmer, F Rigal-Huguet, N Cambier, ... Blood 85 (3), 664-674, 1995 | 254 | 1995 |
| Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’iLOC study by the … C Soussain, S Choquet, M Blonski, D Leclercq, C Houillier, K Rezai, ... European journal of cancer 117, 121-130, 2019 | 224 | 2019 |
| Radiotherapy or autologous stem-cell transplantation for primary CNS lymphoma in patients 60 years of age and younger: results of the intergroup ANOCEF-GOELAMS randomized phase … C Houillier, L Taillandier, S Dureau, T Lamy, M Laadhari, O Chinot, ... Journal of Clinical Oncology 37 (10), 823-833, 2019 | 218 | 2019 |
| Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of … H Ghesquieres, M Chevrier, M Laadhari, O Chinot, S Choquet, ... Annals of Oncology 30 (4), 621-628, 2019 | 190 | 2019 |
| Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS … A Omuro, O Chinot, L Taillandier, H Ghesquieres, C Soussain, V Delwail, ... The Lancet Haematology 2 (6), e251-e259, 2015 | 180 | 2015 |
| Mutational analysis of primary central nervous system lymphoma A Bruno, B Boisselier, K Labreche, Y Marie, M Polivka, A Jouvet, C Adam, ... Oncotarget 5 (13), 5065, 2014 | 179 | 2014 |
| Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network S Langner-Lemercier, C Houillier, C Soussain, H Ghesquières, O Chinot, ... Neuro-oncology 18 (9), 1297-1303, 2016 | 165 | 2016 |
| Primary CNS lymphoma in immunocompetent patients M Sierra del Rio, A Rousseau, C Soussain, D Ricard, K Hoang-Xuan The oncologist 14 (5), 526-539, 2009 | 164 | 2009 |
| Management and outcome of primary CNS lymphoma in the modern era: an LOC network study C Houillier, C Soussain, H Ghesquières, P Soubeyran, O Chinot, ... Neurology 94 (10), e1027-e1039, 2020 | 150 | 2020 |
| Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia … L Simon, A Fitsiori, R Lemal, J Dupuis, B Carpentier, L Boudin, A Corby, ... haematologica 100 (12), 1587, 2015 | 135 | 2015 |
| Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion A Toma, O Kosmider, S Chevret, J Delaunay, A Stamatoullas, C Rose, ... Leukemia 30 (4), 897-905, 2016 | 130 | 2016 |
| Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report ND Doolittle, LE Abrey, TN Shenkier, S Tali, JEC Bromberg, EA Neuwelt, ... Blood, The Journal of the American Society of Hematology 111 (3), 1085-1093, 2008 | 123 | 2008 |
| Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with non‐Hodgkin lymphoma treated with B‐cell depleting immunotherapy R Duléry, S Lamure, M Delord, R Di Blasi, A Chauchet, T Hueso, C Rossi, ... American journal of hematology 96 (8), 934-944, 2021 | 121 | 2021 |
